ARCHIVES

NCI To Offer Advice On Unconventional Therapy. Not Funds

This article is from The Cancer Letter archive.

Vol. 16 No. 48 | December 14, 1990

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005